Trial
NCT00096460
Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Medical College of Wisconsin
Collaborators
National Heart, Lung, and Blood Institute (NHLBI); Blood and Marrow Transplant Clinical Trials Network; National Cancer Institute (NCI); National Marrow Donor Program
Condition
Recurrent Grade 1 Follicular Lymphoma
Intervention
Cyclophosphamide and Rituximab
Why stopped
lower than anticipated accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-01-05